Tandem Diabetes Care, based in San Diego, focuses on products for insulin-dependent diabetes, employing 2,400 staff since its IPO in 2013. Its advanced insulin pumps, including the t:slim X2, feature Control-IQ technology and are compatible with various CGM sensors.
Tandem Diabetes Care (TNDM) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Tandem Diabetes Care's actual EPS was -$0.66, missing the estimate of -$0.62 per share, resulting in a -5.68% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
